177 related articles for article (PubMed ID: 37057215)
1. What is the optimal prolactin cutoff for predicting the presence of a pituitary adenoma in patients with polycystic ovary syndrome?
Kim SI; Yoon JH; Park DC; Yang SH; Kim YI
Int J Med Sci; 2023; 20(4):463-467. PubMed ID: 37057215
[No Abstract] [Full Text] [Related]
2. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
[TBL] [Abstract][Full Text] [Related]
3. Prolactin Level in Polycystic Ovary Syndrome (PCOS): An approach to the diagnosis and management.
Davoudi Z; Araghi F; Vahedi M; Mokhtari N; Gheisari M
Acta Biomed; 2021 Nov; 92(5):e2021291. PubMed ID: 34738596
[TBL] [Abstract][Full Text] [Related]
4. Prolactin secretion in polycystic ovary syndrome (PCOS).
Szosland K; Pawlowicz P; Lewiński A
Neuro Endocrinol Lett; 2015; 36(1):53-8. PubMed ID: 25789595
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome and prolactinoma association.
Yavasoglu I; Kucuk M; Coskun A; Guney E; Kadikoylu G; Bolaman Z
Intern Med; 2009; 48(8):611-3. PubMed ID: 19367058
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
[TBL] [Abstract][Full Text] [Related]
7. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
8. Metoclopramide Test in Hyperprolactinemic Women With Polycystic Ovarian Syndrome: Old Wine Into New Bottles?
Rodier C; Courbière B; Fernandes S; Vermalle M; Florence B; Resseguier N; Brue T; Cuny T
Front Endocrinol (Lausanne); 2022; 13():832361. PubMed ID: 35250884
[TBL] [Abstract][Full Text] [Related]
9. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
10. Etiological diagnosis of hyperprolactinemia.
Cortet-Rudelli C; Sapin R; Bonneville JF; Brue T
Ann Endocrinol (Paris); 2007 Jun; 68(2-3):98-105. PubMed ID: 17524347
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hyperprolactinemia risk factors in infertile women referred to Yazd Infertility Center: A cross-sectional study.
Dehghan E; Namiranian N; Ghadiri-Anari A; Kazem Razavi Ratki S; Azizi R
Int J Reprod Biomed; 2021 Dec; 19(12):1085-1090. PubMed ID: 35098010
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging.
Kawaguchi T; Ogawa Y; Tominaga T
BMC Res Notes; 2014 Aug; 7():555. PubMed ID: 25142896
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma.
Hong JW; Lee MK; Kim SH; Lee EJ
Endocrine; 2010 Feb; 37(1):140-7. PubMed ID: 20963563
[TBL] [Abstract][Full Text] [Related]
14. Determination of the frequency of hyperprolactinemia-related etiologies and the etiology-specific mean prolactin levels.
Korkmaz FN; Gökçay Canpolat A; Şahin M; Çorapçioğlu D
Minerva Endocrinol (Torino); 2021 Sep; ():. PubMed ID: 34528777
[TBL] [Abstract][Full Text] [Related]
15. [Misleading diagnosis of hyperprolactinemia in women].
Paepegaey AC; Veron L; Wimmer MC; Christin-Maitre S
Gynecol Obstet Fertil; 2016 Mar; 44(3):181-6. PubMed ID: 26966035
[TBL] [Abstract][Full Text] [Related]
16. To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study.
Mahboobifard F; Rahmati M; Amiri M; Azizi F; Ramezani Tehrani F
Adv Med Sci; 2022 Mar; 67(1):79-86. PubMed ID: 34998115
[TBL] [Abstract][Full Text] [Related]
17. Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas.
Kim JH; Hur KY; Hong SD; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
World Neurosurg; 2022 Mar; 159():e488-e496. PubMed ID: 34958988
[TBL] [Abstract][Full Text] [Related]
18. Tumoral versus non-tumoral hyperprolactinemia in children and adolescents: possible usefulness of the domperidone test.
Fideleff HL; Azaretzky M; Boquete HR; Pujol AB; Honfi M; Suárez MG; Fideleff G; Giaccio AV
J Pediatr Endocrinol Metab; 2003 Feb; 16(2):163-7. PubMed ID: 12713252
[TBL] [Abstract][Full Text] [Related]
19. [Polycystic ovary syndrome associated with remarkable hyperprolactinemia--case report].
Owecki M; Sowiński J
Pol Merkur Lekarski; 2004 Oct; 17(100):385-7. PubMed ID: 15690710
[TBL] [Abstract][Full Text] [Related]
20. Hyperprolactinemia in children during the peripubertal period--personal observations.
Noczyńska A; Wasikowa R
J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1399-404. PubMed ID: 15526718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
